Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:01:48.848Z.
Consensus retrieved: 2026-10-06T09:50:06.432Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:01:48.848Z.
Quote observation: 2026-10-06T14:51:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3557795f844472894604fcbd35c20595803ff4fe2165ab850e9e673e91650e7f
Forward PE Ratio (N/A) = Dated Quote Price ($0.76) / Consensus Forward EPS ($1.98)
FORWARD PE RATIO
N/A
BeyondSpring Inc.
Market Cap
$31.26M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| BeyondSpring Inc. (BYSI) | $31.26M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $31.28M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.36M | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 9.29 |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | N/A |
| MDxHealth S.A. (MDXH)vs › | $30.86M | N/A |
| CervoMed Inc. (CRVO)vs › | $30.18M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.72M | 10.95 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.04M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.76, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.98 | $1.98 – $1.98 | 1 | 0.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
